Leading Innovation at Intellia
Lunch and Learn
Leading Innovation at Intellia
Laura Sepp-Laurenzino
Chief Scientific Officer, Intellia therapeutics
Wednesday February 19th
12:00-12:45 pm Seminar
12:45-1:15 pm career chat
Albert Sherman AS4-2072
Lunch will be provided
Please RSVP here if you are attending
Laura is currently the chief scientific officer at Intellia Therapeutics, biotech company that develops biopharmaceuticals using CRISPR gene-editing technology. Laura is an innovative leader in drug discovery and development of small molecule and oligonucleotide therapeutics, with over 20 years of experience in academic and industrial settings.
She defines and implements internal and external research strategy, incorporating disruptive, enabling technologies. Dr. Sepp-Lorenzino builds responsive, collaborative teams across geographies and functions and nurtures a learning environment across the organization; coaching, mentoring. She optimizes operations and cost structures, delivering on objectives.
Friday, February 7, 2020
Event Description
Ron will discuss how investment banking can help you start a business and then introduce the Worcester Venture Forum. This is your chance to learn more about the business ecosystem in Worcester. The Venture Forum is a fantastic community that will give you access to other entrepreneurs in central mass while holding several events for learning, networking, and bringing the community together. I highly encourage you to attend and take this opportunity to learn more about the forum and how you can be involved. Career Chat will follow Ron's presentation. See attached flyer for more details and go to https://www.theventureforum.org/.
Wednesday, February 19, 2020
Event Description
Leading Innovation at Intellia
Laura Sepp-Laurenzino
Chief Scientific Officer, Intellia therapeutics
Wednesday February 19th
12:00-12:45 pm Seminar
12:45-1:15 pm career chat
Albert Sherman AS4-2072
Lunch will be provided
Please RSVP here if you are attending
Laura is currently the chief scientific officer at Intellia Therapeutics, biotech company that develops biopharmaceuticals using CRISPR gene-editing technology. Laura is an innovative leader in drug discovery and development of small molecule and oligonucleotide therapeutics, with over 20 years of experience in academic and industrial settings.
She defines and implements internal and external research strategy, incorporating disruptive, enabling technologies. Dr. Sepp-Lorenzino builds responsive, collaborative teams across geographies and functions and nurtures a learning environment across the organization; coaching, mentoring. She optimizes operations and cost structures, delivering on objectives.
